ClinConnect ClinConnect Logo
Search / Trial NCT03016910

Coronary Artery Plaque Burden and Morphology in Type 2 Diabetes Mellitus.

Launched by SVENDBORG HOSPITAL · Jan 8, 2017

Trial Information

Current as of August 15, 2025

Unknown status

Keywords

ClinConnect Summary

Coronary artery disease (CAD) is the leading cause of death and morbidity in type 2 diabetes mellitus (T2DM) and diabetics holds the same risk for death or myocardial infarction (MI) as patients with a prior (MI) without diabetes. In addition to macrovascular complications, and traditional cardiac risk factors, T2DM is burdened by microvascular dysfunction affecting several organs. The dynamics between microvascular dysfunction, known cardiac risk factors and coronary atherosclerosis in diabetic disease is not well characterized.

In the present study, a primary cohort of 300 type 2 diabeti...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age \> 18 years
  • Type 1 or 2 diabetes mellitus
  • Ability to provide informed conscent
  • Exclusion Criteria:
  • History of CAD
  • Symtoms of CAD (angina)
  • Any tachyarrhythmias making CCTA impossible
  • Glumerular filtration rate (GFR)\< 45 ml/min
  • Allergy to iodine contrast
  • Critical illness with life expectancy less than 1 year
  • Documented heart failure

About Svendborg Hospital

Svendborg Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Denmark, the hospital is committed to exploring new treatments and therapies across various medical disciplines, facilitating collaboration between healthcare professionals, researchers, and patients. With a focus on ethical practices and patient safety, Svendborg Hospital aims to contribute valuable insights to the scientific community while enhancing the quality of healthcare services in the region.

Locations

Svendborg, Fyn, Denmark

Patients applied

0 patients applied

Trial Officials

Kenneth Egstrup, Prof. DMSci

Study Director

Head of Reseach, Cardiovascular Research Unit, OUH Svendborg Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials